Poster: ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Mehdi Hamadani,Christopher Graham,Laura Liao, Kate Zhang,Hannah Strat,David Ungar,Weiyun Ai,Lei Chen,Carmelo Carlo-Stella

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览7

暂无评分

摘要

The observed survival plateau suggests Lonca-treated patients may include LTS. Multiple models fit the trial data well and align on survival projections. Additional follow-up may help refine the switch point of the hybrid model and confirm presence of LTS. ©2022 American Society of Clinical Oncology, Inc. Reused with permission. All rights reserved.

查看译文

关键词

ABCL,health services research,DLBCL,non-Hodgkin lymphoma,survival projection,loncastuximab tesirine,Phase II

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要